Pharmalex
Entry
2014
Hold
8yr
Exit
2022
Who owns Pharmalex?
Pharmalex was owned by Auctus Capital Partners through Auctus III (2011 vintage) from 2014 to 2022, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-10
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022
More from Auctus III
Other portfolio companies in the same fund.
TimePartner
Exited 2016
Business Services
Germany· 2014
Germany· 2014to
Avedo
Exited 2017
Business ServicesGermany· 2013
Germany· 2013to
Light Metal Casting Solutions Group (StrikoWestofen + ITALPRESSE + Gauss)
Exited 2017
IndustrialsGermany· 2013
Germany· 2013to
Striko Westofen
Active
IndustrialsGermany· 2013
Germany· 2013unimed
Active
Business ServicesGermany· 2013
Germany· 2013valantic
Exited 2019
IT ServicesGermany· 2013
Germany· 2013to
More PE-backed in Pharma
Comparable pharma deals from other GPs.
US
FranceTrack Pharmalex
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Pharmalex?
6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Pharmalex.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue